Lunai Bioworks Inc.
For the period ended Jun 30, 2026. Filed Oct 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Oct 13, 2026
LNAI$0.16-30.2%Stored close · as of Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Lunai Bioworks Inc. AND SUBSIDIARIES
Index to Consolidated Financial Statements
| Page | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID:3627) | F-2 |
|---|---|
| Consolidated Balance Sheets at June 30, 2026 and 2025 | F-4 |
| Consolidated Statements of Operations for the Years Ended June 30, 2026 and 2025 | F-5 |
| Consolidated Statements of Comprehensive Loss for the Years Ended June 30, 2026 and 2025 | F-6 |
| Consolidated Statement of Stockholders’ Equity (Deficit) for the Years Ended June 30, 2026 and 2025 | F-7 |
| Consolidated Statements of Cash Flows for the Years Ended June 30, 2026 and 2025 | F-8 |
| Notes to the Consolidated Financial Statements | F-9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.